What is the recommended dialysate sodium concentration for adult patients on thrice‑weekly hemodialysis, and how should it be adjusted based on predialysis serum sodium, interdialytic weight gain, and intradialytic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dialysate Sodium Management in Hemodialysis

For adult patients on thrice-weekly hemodialysis, use lower dialysate sodium concentrations (135-138 mEq/L) rather than higher concentrations (≥140 mEq/L) to reduce interdialytic weight gain and improve blood pressure control, while accepting that this may require careful monitoring for intradialytic hypotension. 1

Recommended Dialysate Sodium Concentration

The evidence strongly supports avoiding high dialysate sodium concentrations (≥140 mEq/L) and discouraging sodium profiling for most patients. 1 The 2006 KDOQI guidelines explicitly state that "to more easily control hypertension in most dialysis patients, use of a high dialysate sodium concentration and sodium profiling should be discouraged." 1

Standard Approach:

  • Target dialysate sodium: 135-138 mEq/L for most patients
  • Historical context: In the 1960s with 6-hour treatments, dialysate sodium was ~135 mEq/L; this increased to ~140 mEq/L in the 1990s with shorter treatments, but this change aggravated thirst, fluid gain, and hypertension 1

Adjustments Based on Clinical Parameters

For Predialysis Serum Sodium:

Individualize dialysate sodium based on the patient's predialysis plasma sodium:

  • Set dialysate sodium to 0.95 × average predialysis plasma sodium 2
  • This approach significantly reduces interdialytic weight gain (from 2.91 kg to 2.29 kg), thirst scores, and intradialytic hypotension episodes 2
  • In patients with uncontrolled baseline BP, this reduces predialysis BP by 15.6/6.5 mmHg 2

For Excessive Interdialytic Weight Gain:

When patients have large interdialytic weight gains:

  1. First-line: Lower dialysate sodium concentration

    • Reducing from 140 to 136-134 mEq/L decreases interdialytic weight gain by 0.6 kg and predialysis systolic BP by 8.3 mmHg 3
    • Dialysate sodium 140 mEq/L produces 3.5-4.1% weight gain vs. 2.7-2.8% with 136-137 mEq/L 4
  2. Concurrent dietary sodium restriction to 100 mmol/day 1

  3. If inadequate, extend treatment time rather than increasing dialysate sodium 5, 6

    • Consider additional sessions or longer treatment times 5
    • Extend session duration to lower hourly ultrafiltration rate 6

For Intradialytic Hypotension:

This is where the evidence becomes nuanced and requires careful clinical judgment:

If intradialytic hypotension occurs, DO NOT immediately increase dialysate sodium. Instead, follow this algorithm:

  1. Reassess estimated dry weight (EDW) - hypotension cannot define intravascular volume 6

    • Look for: increased dietary intake + rising serum albumin/creatinine/NPCR in presence of hypotension (suggests EDW too low) 6
  2. Modify ultrafiltration approach:

    • Slow ultrafiltration rate 6
    • Extend treatment time to reduce hourly UF rate 6
    • Consider isolated ultrafiltration followed by diffusive clearance 6
  3. Other dialysate modifications (before increasing sodium):

    • Reduce dialysate temperature to 34-35°C (decreases symptomatic hypotension from 44% to 34%) 6
    • Ensure bicarbonate-buffered (not acetate) dialysate 6
  4. Pharmacologic intervention:

    • Administer midodrine 5 mg 30 minutes predialysis 6
  5. Only if above measures fail: Consider temporary increase in dialysate sodium to 148 mEq/L with sodium ramping 6

    • Critical caveat: This may increase interdialytic weight gain and blood pressure 6

Important Clinical Pitfalls

The Dialysate Sodium Paradox:

  • Higher dialysate sodium (≥140 mEq/L) reduces intradialytic hypotension BUT increases interdialytic weight gain, thirst, hypertension, and paradoxically increases symptomatic intradialytic hypotension requiring IV fluid (13.5% vs 2.7% with lower sodium) 4
  • Recent RCT data: Raising dialysate sodium from 135 to 140 mEq/L reduced intradialytic hypotension (OR 0.66) but markedly increased predialysis BP by 7.0/3.9 mmHg 7

The Lag Phenomenon:

  • When achieving volume control with lower dialysate sodium, do not interpret transient intradialytic hypotension or interdialytic hypertension as treatment failure 1
  • Blood pressure normalization may take weeks to months after achieving true dry weight 1

Sodium Profiling Should Be Avoided:

  • Despite theoretical benefits, sodium profiling (starting high at 145-155 mEq/L, decreasing to 135-140 mEq/L) causes postdialysis hypernatremia, thirst, dysphoria, hypertension, and increased interdialytic weight gain 8, 1

Evidence Quality Considerations

The most recent high-quality RCT 7 from 2024 found that lowering dialysate sodium from 138 to 135 mEq/L produced minimal benefit (small reduction in weight gain, no BP change) but increased symptoms. However, this contradicts multiple earlier studies 2, 3, 4 showing clear benefits. The key difference: the 2024 study compared 135 vs 138 mEq/L (small difference), while earlier studies compared lower concentrations against 140+ mEq/L (larger difference).

Clinical synthesis: The evidence consistently supports avoiding dialysate sodium ≥140 mEq/L. The optimal concentration between 135-138 mEq/L should be individualized based on predialysis serum sodium (using the 0.95× formula) rather than using a fixed concentration for all patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.